Beverly Hills Private Wealth’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Buy |
37,562
+4,464
| +13% | +$171K | 0.27% | 97 |
|
|
2025
Q1 | $1.28M | Buy |
33,098
+3,701
| +13% | +$143K | 0.25% | 103 |
|
|
2024
Q4 | $994K | Buy |
29,397
+14,288
| +95% | +$483K | 0.2% | 119 |
|
|
2024
Q3 | $618K | Buy |
15,109
+2,163
| +17% | +$88.4K | 0.12% | 160 |
|
|
2024
Q2 | $498K | Sell |
12,946
-11,555
| -47% | -$445K | 0.11% | 187 |
|
|
2024
Q1 | $1.05M | Buy |
24,501
+5,190
| +27% | +$222K | 0.24% | 101 |
|
|
2023
Q4 | $716K | Buy |
19,311
+2,009
| +12% | +$74.5K | 0.19% | 120 |
|
|
2023
Q3 | $627K | Sell |
17,302
-6,681
| -28% | -$242K | 0.19% | 120 |
|
|
2023
Q2 | $825K | Buy |
23,983
+18,133
| +310% | +$623K | 0.14% | 161 |
|
|
2023
Q1 | $208K | Buy |
+5,850
| New | +$208K | 0.06% | 258 |
|